MyLife Technologies


MyLife Technologies is dedicated to advancing healthcare through innovative nanotechnology solutions, focusing on areas such as nanoporous microneedle array technology, small molecules, vaccines, peptides, and collaboration pipeline projects. Their mission is to develop cutting-edge technologies to improve medical treatments and delivery systems.

Industries

biotechnology
health-care
information-technology-dbca

Nr. of Employees

small (1-50)

MyLife Technologies


Patents

Integrated microneedle array and a method for manufacturing thereof

US-10413711-B2

View Details

Products

CeraMAPs™

A technology utilizing nano-porous ceramic microneedles for targeted, painless, and efficient vaccine delivery directly into the skin.

Ceramic Skin Patches

Skin patches that use ceramic microneedles to improve vaccine delivery, reduce dosage, and avoid needle anxiety.

Nano Porous Technology

A technology that enhances vaccine delivery efficiency by using nano-porous microneedles to reduce antigen dosage and eliminate the need for adjuvants.


Services

Collaborative development projects and partnership-based advancement of drug delivery and therapeutic candidates.

Support for intellectual property strategy and licensing of platform technologies.

Expertise Areas

  • Drug delivery systems
  • Vaccine development
  • Small-molecule therapeutics
  • Peptide therapeutics
  • Show More (3)

Key Technologies

  • Nanoporous microneedle arrays
  • Transdermal drug delivery
  • Vaccine delivery platforms
  • Small-molecule discovery and development methods
  • Show More (1)

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.